Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
January 28, 2019
Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients
WARREN, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that data from the ...
January 28, 2019
Theravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
DUBLIN, Jan. 28, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of the first patient in a registrational Phase ...
January 24, 2019
Changes to Zealand Pharma’s Executive Management
Copenhagen, Denmark, January 23, 2019 – Zealand Pharma A/S today announced changes to its Executive Management. Following the resignation of Britt Meelby Jensen on 26 ...
January 24, 2019
HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program
TUCSON, Ariz., Jan. 23, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a life science company whose mission is to advance precision medicine, ...
January 24, 2019
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
NEW YORK--(BUSINESS WIRE)--UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on ...
January 24, 2019
Basilea announces collaboration to study derazantinib and atezolizumab (Tecentriq®) in urothelial cancer
Basel, Switzerland, January 24, 2019 - Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that it entered into a collaboration with Roche (SIX: RO, ROG) to explore ...
January 24, 2019
AIT Enters into $32.5 million Commercial Licensing Agreement with Circassia Pharmaceuticals for Its Novel Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and China
GARDEN CITY, N.Y. and REHOVOT, Israel, Jan. 24, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
January 24, 2019
Basilea Announces Collaboration to Study Derazantinib and Atezolizumab (Tecentriq®) in Urothelial Cancer
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc.’s (ARQL) partner, Basilea Pharmaceutica Ltd. (SIX:BSLN), announced today that it entered into a collaboration with Roche (SIX: RO, ROG) to explore ...
January 24, 2019
Lipocine Files IND To Evaluate LPCN 1144 In Biopsy Confirmed NASH Subjects
SALT LAKE CITY, Jan. 24, 2019 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug application ("IND") ...
January 24, 2019
InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study Comparing CGuard™ EPS with a Conventional Open-Cell Carotid Stent
TEL AVIV, Israel, Jan. 24, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
January 8, 2019
Novus Therapeutics Doses First Patient with Acute Otitis Media in Phase 1 Study of OP0201
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), ...
January 8, 2019
electroCore Announces Two New Studies and a Publication Supporting the Practical Utility of Non-invasive Vagus Nerve Stimulation in Adults
BASKING RIDGE, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, today announced two clinical studies focused on expanding ...
January 3, 2019
Cormedix Announces Closing of $7.5 Million Senior Secured Convertible Debt Financing
BERKELEY HEIGHTS, NJ / ACCESSWIRE / January 3, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
January 3, 2019
Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease
IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced that it has completed a successful end-of-Phase ...
January 3, 2019
Chiasma Previews Important Upcoming Milestones
WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
January 3, 2019
DURECT Corporation Announces Investor Call to Provide Corporate Update
CUPERTINO, Calif., Jan. 3, 2019 /PRNewswire/ -- DURECT Corporation (DRRX) invites interested parties to listen to a corporate update conference call that will be broadcast live ...
January 3, 2019
Kiadis Pharma to present at Biotech Showcase 2019
Amsterdam, The Netherlands, January 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today ...
January 3, 2019
AC Immune Announces Appointment of Dr. Marie Kosco-Vilbois as Chief Scientific Officer
Lausanne, Switzerland, January 3, 2019 - AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on Neurodegenerative Diseases, today announced ...
January 3, 2019
UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer
UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today ...
January 3, 2019
ProQR to Host R&D Day in New York on January 29
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR) will host a Research & Development Day for investors on ...
Page 8 of 128